Kura Oncology (KURA) Other Non-Current Assets (2014 - 2026)

Kura Oncology (KURA) has 13 years of Other Non-Current Assets data on file, last reported at $14.0 million in Q1 2026.

• On a quarterly basis, Other Non-Current Assets rose 54.09% year-over-year to $14.0 million in Q1 2026; TTM through Mar 2026 was $14.0 million, a 54.09% increase from a year earlier, with the FY2025 full-year figure at $14.5 million, up 85.38% from the prior year.
• Other Non-Current Assets for Q1 2026 stood at $14.0 million, down from $14.5 million in the prior quarter.
• Over the last five years, Other Non-Current Assets for KURA reached as high as $14.5 million in Q4 2025 and fell as low as $210000.0 in Q1 2022.
• Historically, Other Non-Current Assets has averaged $6.7 million across 5 years, with a median of $7.6 million in 2023.
• Across the five-year window, Other Non-Current Assets changed 0.0% in 2022 and soared 3435.71% in 2024, its largest moves.
• Year by year, Other Non-Current Assets stood at $3.5 million in 2022, then surged by 117.32% to $7.6 million in 2023, then grew by 3.2% to $7.8 million in 2024, then jumped by 85.38% to $14.5 million in 2025, then decreased by 3.8% to $14.0 million in 2026.
• Per Business Quant data, the three most recent Other Non-Current Assets figures were $14.0 million in Q1 2026, $14.5 million in Q4 2025, and $13.8 million in Q3 2025.